![]() |
市场调查报告书
商品编码
1479070
全球腔内缝合设备市场评估:依产品、组件、应用、最终用户、地区、机会、预测(2017-2031)Endoluminal Suturing Devices Market Assessment, By Product, By Component, By Application, By End-User, By Region, Opportunities and Forecast, 2017-2031F |
全球腔内缝合器材市场规模预计将从 2023 年的 9,128 万美元增至 2031 年的 1.9,638 亿美元,在 2024-2031 年的预测期内复合年增长率为 10.05%。对非侵入性手术的日益偏好、胃肠道癌症盛行率的增加以及医疗部门的扩大支持了市场的扩张。
慢性病盛行率的增加是全球腔内缝合器材市场的主要趋势之一。这一增长是由于腔内缝合装置在胃肠手术、减肥手术、胃食道逆流、胸腔外科、泌尿外科手术等中发挥重要作用。在减重手术中,这些设备被用来执行各种手术,例如胃绕道术和胃套,以帮助患者透过减重来控制肥胖相关的併发症。人们对这些设备越来越青睐的部分原因可能是它们能够以微创方式治疗健康状况、提供更快的康復、降低手术风险并提高患者的生活品质。
人们越来越关注提高医疗保健系统的效率和成本效益,这为市场提供了利润丰厚的成长机会。腔内缝合装置可以帮助医疗保健提供者优化资源,同时降低与长期住院相关的成本。胃肠道疾病患者数量的不断增加,进一步增加了对腔内缝合器械的需求。根据2022年7月至2023年5月的问卷调查,海南省功能性胃肠病情为32%。加强医疗基础设施投资的增加和人口的快速成长也是推高全球腔内缝合器材市场规模的主要因素。
对微创手术的日益青睐支持市场扩张
由于人们对微创手术相关各种好处的认识不断增强,人们对微创手术的偏好日益增加,这对市场扩张产生了积极影响。微创手术可减少併发症、减少疼痛并缩短住院时间。这些仪器帮助外科医生在解剖学上困难的位置和体腔内进行精确的缝合。该仪器提供的更高的可操作性和控制能力使外科医生能够获得更好的手术结果。它还可以缩短康復时间、降低感染风险并提高患者满意度。腔内缝合装置还允许外科医生在内部缝合组织,从而无需大切口。这将推动需求并对市场扩张产生积极影响。
技术进步推动全球腔内缝合器材市场
不断增加的研究和开发有助于提高腔内缝合设备的功能性、易用性和精确度,正在推动市场成长。机器人技术的使用为外科医生提供了灵巧而精确的动作,以及符合人体工学和直觉的操作。人们对手术过程中微创性的日益偏好,加上机器人技术的进步,正在支持灵活手术机器人的出现。此外,结合内视镜检查和萤光透视等影像技术可实现即时视觉化,从而改善缝合过程中的手术结果。技术进步支持开发具有数据管理和无线连接功能的先进腔内缝合设备,能够即时监控手术指标和设备参数,从而为市场提供利润丰厚的成长机会。
各主要市场参与者增加研发投资也支持使用先进技术的腔内缝合装置的开发。2022 年,波士顿科学公司在浦那开设了最先进的研发中心。该中心提供内视镜、泌尿科、心臟病学和神经调节等多个领域的专业知识。
北美占有很大的市场占有率
支持北美腔内缝合器械市场成长的因素包括成熟的医疗基础设施、外科手术需求的不断增长以及各种主要市场参与者的强势布局。该地区的市场成长也归因于优惠报销政策的推出和大量患者群体的可用性。此外,加拿大和美国等国家对微创手术的需求正在增加。微创手术可降低感染、出血、疤痕和恢復时间等风险。腔内缝合器械在此类手术中发挥重要作用,使外科医生能够透过较小的切口进行缝合。该地区肥胖治疗数量的增加进一步支持了北美市场的扩张。美国代谢与减重手术协会American Society for Metabolic and Bariatric Surgery估计,2022 年进行的减重手术总数为 279,967 例。
本报告研究和分析了全球腔内缝合器材市场,提供市场规模和预测、市场动态以及主要参与者的现状和前景。
Global endoluminal suturing devices market is projected to witness a CAGR of 10.05% during the forecast period 2024-2031, growing from USD 91.28 million in 2023 to USD 196.38 million in 2031F. The expansion of the market is supported by the increase in preference for non-invasive surgical procedures, growth in prevalence of gastrointestinal cancer, and the expansion of the healthcare sector.
The increasing prevalence of chronic diseases is one of the major global endoluminal suturing devices market trends. This increase is propelling the requirement for various efficient surgical solutions, including endoluminal suturing devices, as they play a crucial role in gastrointestinal surgeries, bariatric surgeries, gastroesophageal reflux disease, thoracic procedures, and urological procedures, among others. In bariatric surgery, these devices are deployed for performing different procedures, including gastric bypass and gastric sleeve, aiding patients in managing obesity-related comorbidities by achieving weight loss. The increased preference for these devices can also be attributed to their ability to treat the health condition in a minimally invasive manner, provide faster recovery and reduce surgical risks and improving the quality of life of the patient.
The rising emphasis on increasing the efficiency and cost-effectiveness of healthcare systems is providing lucrative growth opportunities for the market. Endoluminal suturing devices aid healthcare providers in reducing costs associated with extended hospital stays while allowing them to optimize resources. The growing number of cases of gastrointestinal disorders is further boosting the requirement for endoluminal suturing devices. According to a questionnaire survey conducted from July 2022 to May 2023, in Hainan, the prevalence of functional gastrointestinal diseases was 32%. The growing investments towards the enhancement of healthcare infrastructure and rapid population expansion are other major factors boosting the global endoluminal suturing devices market size.
Increasing Preference for Minimally Invasive Procedures Supports Market Expansion
The rising preference for minimally invasive procedures due to growing awareness about the various advantages associated with them is positively influencing the expansion of the market. Minimally invasive procedures are linked with fewer complications, less pain, and shorter hospitalizations. These devices aid surgeons in performing precise suturing in anatomically challenging locations and body cavities. The greater maneuverability and control offered by the devices further allow surgeons to achieve optimal surgical outcomes. The devices are also associated with faster recovery times, reduced risk of infection, and improved patient satisfaction. Endoluminal suturing devices also eliminate the requirement for large incisions by allowing surgeons to suture tissues internally, thus boosting their demand and positively influencing market expansion.
Technological Advancements Boost Global Endoluminal Suturing Devices Market
The increasing research and development efforts to support the enhancement of the functionality, ease of use, and precision offered by endoluminal suturing devices are driving the growth of the market. The utilization of robotic technology provides surgeons with dexterous and precise motions along with ergonomic and intuitive manipulation. The increased preference for minimal invasiveness during surgeries, coupled with technological advancements in robotics, has supported the emergence of flexible surgical robots. Additionally, the incorporation of imaging technologies, such as endoscopy and fluoroscopy, provides real-time visualization that improves procedural outcomes during the suturing process. Technological advancements will support the development of advanced endoluminal suturing devices that will feature data management capabilities and wireless connectivity, allowing the real-time monitoring of surgical metrics and device parameters, thus providing lucrative growth opportunities to the market.
The rising investments by various key market players in research and development will also support the development of technologically advanced endoluminal suturing devices. In 2022, Boston Scientific launched a state-of-the-art research and development center in Pune. The center provides expertise in diverse areas, including endoscopy, urology, cardiology, and neuromodulation, among others.
North America Holds Significant Share of the Market
The presence of a well-established healthcare infrastructure, the increasing requirement for surgical procedures, and the strong placement of various leading market players are some of the factors supporting the growth of the North America endoluminal suturing devices market. The growth of the market in the region can also be attributed to the introduction of favorable reimbursement policies and the availability of a large patient pool. The demand for minimally invasive procedures is also increasing in countries such as Canada and the United States, as they reduce the risk of infection, blood loss, scarring, and time of recovery. Endoluminal suturing devices allow surgeons to internally perform suturing with smaller incisions, playing an essential role in such procedures. The rise in the number of bariatric procedures in the region is further boosting the expansion of the market in North America. According to the estimates of the American Society for Metabolic and Bariatric Surgery, the total number of bariatric surgeries conducted in 2022 was 279,967.
Gastrointestinal Surgery Dominates the Market
The rising requirement for gastrointestinal surgeries can be attributed to the increasing occurrence of gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. According to the estimates of the International Agency for Research on Cancer, gastrointestinal cancer accounts for one in three cancer related deaths and one in four cancer cases across the globe.
Gastrointestinal perforations occur because of surgical complications, ulcers, and trauma. The endoluminal suturing devices are used for closing these perforations in order to prevent the leakage of gastric contents in the abdominal cavity. Therefore, the availability of effective endoluminal suturing devices is essential for the proper management of gastrointestinal perforations. Endoluminal suturing devices also allow surgeons to endoscopically close leaks that can occur at the site of anastomosis after gastrointestinal surgeries, avoiding the requirement for additional invasive surgeries.
Hospitals Account for a Significant Global Endoluminal Suturing Devices Market Share
The segment expansion is supported by the increased requirement for surgical procedures in various regions across the globe. The rising demand for surgical procedures can be attributed to the growing prevalence of chronic health diseases that require surgical procedures for further exploration of the condition in order to give an appropriate diagnosis. These procedures also help in treating various pathological conditions, such as malignancy, trauma, and injury. The rising investments by various hospitals to meet evolving patient requirements and provide advanced medical care is another major factor bolstering the demand for endoluminal suturing devices from hospitals. In April 2024, the construction of UCSF Health Helen Diller Hospital was initiated. The hospital is expected to cost USD 4.3 billion and will have 15 stories. The design of this new hospital will integrate care and advanced science to provide a healing habitat for the patients. The facility will have the latest technologies in diagnostics, robotics, and surgical procedures. The construction of such state-of-the-art facilities in this evolving landscape of healthcare is a testament to the commitment provided by the sector to support the advancement of patient care.
Future Market Scenario (2024-2031F)
According to the global endoluminal suturing devices market analysis, the market is anticipated to witness significant growth over the forecast period 2024-2031. This growth can be attributed to expanding healthcare sector, rising investments in research and development activities, and increasing prevalence of various health conditions such as gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. The increasing collaborations between healthcare providers and medical device manufacturers will drive innovation, supporting the development of advanced endoluminal devices and boosting the expansion of the market.
Key Players Landscape and Outlook
The key players of the endoluminal suturing devices market include Apollo Endosurgery, Inc. (Boston Scientific Corporation), B. Braun SE, Medtronic plc, Johnson & Johnson, and Cook Medical. The expansion of the market is supported by increasing investments in research and development activities, collaborations, and successful mergers and acquisitions.
In 2023, Boston Scientific successfully completed the acquisition of Apollo Endosurgery. Apollo's product portfolio includes different devices required in endoluminal surgery procedures. The endoluminal surgery procedures aid in managing gastrointestinal complications and close gastrointestinal defects. These procedures are also employed due to their less-invasive nature as opposed to laparoscopic and open surgeries. With the closure of this acquisition, the companies aim to provide a comprehensive suite of endobariatric and endoluminal surgery solutions to their patients.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work